More recent studies have since identified such transcriptional regulators, most notably the TF SOX2, which has been found to drive cancer progression through driving expression of both ST6GAL1 (Dorsett et al., 2019) (in ovarian cancer) and ST3GAL1 (Pietrobono et al., 2020) (in metastatic melanoma). Here, TF is linked to cancer.